Dr. R. (Rob) van der Pas | Internist-nefroloog

Studie & opleiding

• Geneeskunde aan de Erasmus universiteit (Rotterdam).
• Promotieonderzoek afdeling endocrinologie (Erasmus MC).
• Opleiding tot internist in het St. Elisabeth ziekenhuis en Radboudumc.

Onderzoek & publicaties

• R. van der Pas, C. de Bruin, F.W.G. Leebeek, M.P.M. de Maat, D.C. Rijken, A.M. Pereira, J.A. Romijn, R.T. Netea-Maier, A.R. Hermus, P.M.J. Zelissen, F.H. de Jong, A.J. van der Lely, W.W. de Herder, S.W.J. Lamberts, L.J. Hofl and, R.A. Feelders. The Hypercoagulable State in Cushing’s Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy
  J Clin Endocrinol Metab. 2012; 97: 1303-10.
• R. van der Pas, W.W. de Herder, L.J. Hofl and, R.A. Feelders. New developments in the Medical Treatment of Cushing’s syndrome. Endocrine Related Cancer 2012; 19: R205-23.
• R. van der Pas, L.J. Hofl and, J. Hofl and, A.E. Taylor, W. Arlt, J. Steenbergen, P.M. van Koetsveld, W.W. de Herder, F.H. de Jong, R.A. Feelders. Fluconazole Inhibits Human Adrenocortical Steroidogenesis In Vitro. J of Endocrinology 2012; 215: 403-12.
• F. Gatto, R.A. Feelders, R. van der Pas, J.M. Kros, A.M. Waaijers, D.M. Sprij-Mooij, S.J. Neggers, A.J. van der Lely, F. Minuto, S.W.J. Lamberts, W.W. de Herder, D. Ferone, L.J. Hofl anw. Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly. J Clin Endocrinol Metab 2013; 98: E66-71.
• R. van der Pas, F.W.G. Leebeek, L.J. Hofl and, W.W. de Herder, R.A. Feelders. Hypercoagulability in Cushing’s syndrome: prevalence, pathogenesis and treatment. Clin Endocrinol (Oxf) 2013; 78: 481-88
• R. van der Pas, C. de Bruin, A.M. Pereira, J.A. Romijn, R.T. Netea-Maier, A.R. Hermus, P.M. Zelissen, F.H. de Jong, A.J. van der Lely, W.W. de Herder, S.M. Webb, S.W.J. Lamberts, L.J. Hofl and, R.A. Feelders. Cortisol Diurnal Rhythm and Quality of Life after Successful Medical Treatment of Cushing’s Disease. Pituitary 2013; 16(4): 536-44.
• R. van der Pas, W.W. de Herder, L.J. Hofl and, R.A. Feelders. Recent developments in drug therapy for Cushing’s disease. Drugs 2013; 73; 907-18.
• R. van der Pas, R.A. Feelders, C. de Bruin, A.M. Pereira, D.M. Sprij-Mooij, A.M. Waaijers, S. Schulz, S.W.J. Lamberts, L.J. Hofl and. Normalization of cortisol levels in Cushing’s disease after medical pretreatment before surgery: consequences for somatostatin receptor subtype expression and in vitro response to somatostatin analogs. J. Clin Endocr Metab 2013; 98; 1880-90.
• R. van der Pas, J.H.M. van Esch, A.H.J. Danser, C. de Bruin, D.M. Sprij-Mooij, I.M. van den Berg-Garrelds, A.H. van den Meiracker, L.J. Hofl and, R.A. Feelders. Cushing’s disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and eff ects of medical therapy. Eur J Endocrinol 2014; 170; 181-91.
• F. Gatto, R.A. Feelders, R. van der Pas, J.M. Kros, F. Dogan, P.M. van Koetsveld, A.J. van der Lely, S.J. Neggers, F. Minuto, W.W. de Herder, S.W.J. Lamberts, D. Ferone, L.J. Hofl and. Beta-arrestin 1 and 2 and G-protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly. Endocrinology 2013; 154; 4715-25.
• F. Gatto, R.A. Feelders, R. van der Pas, P. van Koetsveld, E. Bruzzone, M. Arvigo, F. Dogan, S. Lamberts, D. Ferone, L. Hofl and. 􀀀-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids. J. Endocrinol. 2020; 245(1); 101-113.

Lidmaatschappen

• Nederlandse internistenvereniging, Nederlandse federatie voor nefrologie

• Dialysecentrum